guest ::
| Home > Publications database > Glycemic index, glycemic load, and risk of coronary heart disease: a pan-European cohort study. > print |
| Home > Publications database > Glycemic index, glycemic load, and risk of coronary heart disease: a pan-European cohort study. > print |
| 001 | 156857 | ||
| 005 | 20240229123119.0 | ||
| 024 | 7 | _ | |a 10.1093/ajcn/nqaa157 |2 doi |
| 024 | 7 | _ | |a pmid:32619242 |2 pmid |
| 024 | 7 | _ | |a 0002-9165 |2 ISSN |
| 024 | 7 | _ | |a 0095-9871 |2 ISSN |
| 024 | 7 | _ | |a 1938-3207 |2 ISSN |
| 024 | 7 | _ | |a 1938-3215 |2 ISSN |
| 024 | 7 | _ | |a altmetric:85185630 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2020-01174 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 570 |
| 100 | 1 | _ | |a Sieri, Sabina |b 0 |
| 245 | _ | _ | |a Glycemic index, glycemic load, and risk of coronary heart disease: a pan-European cohort study. |
| 260 | _ | _ | |a Oxford |c 2020 |b Oxford University Press |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1602762199_3285 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a 2020 Sep 1;112(3):631-643 |
| 520 | _ | _ | |a High carbohydrate intake raises blood triglycerides, glucose, and insulin; reduces HDLs; and may increase risk of coronary heart disease (CHD). Epidemiological studies indicate that high dietary glycemic index (GI) and glycemic load (GL) are associated with increased CHD risk.The aim of this study was to determine whether dietary GI, GL, and available carbohydrates are associated with CHD risk in both sexes.This large prospective study-the European Prospective Investigation into Cancer and Nutrition-consisted of 338,325 participants who completed a dietary questionnaire. HRs with 95% CIs for a CHD event, in relation to intake of GI, GL, and carbohydrates, were estimated using covariate-adjusted Cox proportional hazard models.After 12.8 y (median), 6378 participants had experienced a CHD event. High GL was associated with greater CHD risk [HR 1.16 (95% CI: 1.02, 1.31) highest vs. lowest quintile, p-trend 0.035; HR 1.18 (95% CI: 1.07, 1.29) per 50 g/day of GL intake]. The association between GL and CHD risk was evident in subjects with BMI (in kg/m2) ≥25 [HR: 1.22 (95% CI: 1.11, 1.35) per 50 g/d] but not in those with BMI <25 [HR: 1.09 (95% CI: 0.98, 1.22) per 50 g/d) (P-interaction = 0.022). The GL-CHD association did not differ between men [HR: 1.19 (95% CI: 1.08, 1.30) per 50 g/d] and women [HR: 1.22 (95% CI: 1.07, 1.40) per 50 g/d] (test for interaction not significant). GI was associated with CHD risk only in the continuous model [HR: 1.04 (95% CI: 1.00, 1.08) per 5 units/d]. High available carbohydrate was associated with greater CHD risk [HR: 1.11 (95% CI: 1.03, 1.18) per 50 g/d]. High sugar intake was associated with greater CHD risk [HR: 1.09 (95% CI: 1.02, 1.17) per 50 g/d].This large pan-European study provides robust additional support for the hypothesis that a diet that induces a high glucose response is associated with greater CHD risk. |
| 536 | _ | _ | |a 313 - Cancer risk factors and prevention (POF3-313) |0 G:(DE-HGF)POF3-313 |c POF3-313 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 700 | 1 | _ | |a Agnoli, Claudia |b 1 |
| 700 | 1 | _ | |a Grioni, Sara |b 2 |
| 700 | 1 | _ | |a Weiderpass, Elisabete |b 3 |
| 700 | 1 | _ | |a Mattiello, Amalia |b 4 |
| 700 | 1 | _ | |a Sluijs, Ivonne |b 5 |
| 700 | 1 | _ | |a Sanchez, Maria Jose |b 6 |
| 700 | 1 | _ | |a Jakobsen, Marianne Uhre |b 7 |
| 700 | 1 | _ | |a Sweeting, Michael |b 8 |
| 700 | 1 | _ | |a van der Schouw, Yvonne T |b 9 |
| 700 | 1 | _ | |a Nilsson, Lena Maria |b 10 |
| 700 | 1 | _ | |a Wennberg, Patrik |b 11 |
| 700 | 1 | _ | |a Katzke, Verena A |0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4 |b 12 |u dkfz |
| 700 | 1 | _ | |a Kühn, Tilman |0 P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe |b 13 |u dkfz |
| 700 | 1 | _ | |a Overvad, Kim |b 14 |
| 700 | 1 | _ | |a Tong, Tammy Y N |b 15 |
| 700 | 1 | _ | |a Conchi, Moreno-Iribas |b 16 |
| 700 | 1 | _ | |a Quirós, José Ramón |b 17 |
| 700 | 1 | _ | |a García-Torrecillas, Juan Manuel |b 18 |
| 700 | 1 | _ | |a Mokoroa, Olatz |b 19 |
| 700 | 1 | _ | |a Gómez, Jesús-Humberto |b 20 |
| 700 | 1 | _ | |a Tjønneland, Anne |b 21 |
| 700 | 1 | _ | |a Sonestedt, Emiliy |b 22 |
| 700 | 1 | _ | |a Trichopoulou, Antonia |b 23 |
| 700 | 1 | _ | |a Karakatsani, Anna |b 24 |
| 700 | 1 | _ | |a Valanou, Elissavet |b 25 |
| 700 | 1 | _ | |a Boer, Jolanda M A |b 26 |
| 700 | 1 | _ | |a Verschuren, W M Monique |b 27 |
| 700 | 1 | _ | |a Boutron-Ruault, Marie-Christine |b 28 |
| 700 | 1 | _ | |a Fagherazzi, Guy |b 29 |
| 700 | 1 | _ | |a Madika, Anne-Laure |b 30 |
| 700 | 1 | _ | |a Bergmann, Manuela M |b 31 |
| 700 | 1 | _ | |a Schulze, Matthias B |b 32 |
| 700 | 1 | _ | |a Ferrari, Pietro |b 33 |
| 700 | 1 | _ | |a Freisling, Heinz |b 34 |
| 700 | 1 | _ | |a Lennon, Hannah |b 35 |
| 700 | 1 | _ | |a Sacerdote, Carlotta |b 36 |
| 700 | 1 | _ | |a Masala, Giovanna |b 37 |
| 700 | 1 | _ | |a Tumino, Rosario |b 38 |
| 700 | 1 | _ | |a Riboli, Elio |b 39 |
| 700 | 1 | _ | |a Wareham, Nicholas J |b 40 |
| 700 | 1 | _ | |a Danesh, John |b 41 |
| 700 | 1 | _ | |a Forouhi, Nita G |b 42 |
| 700 | 1 | _ | |a Butterworth, Adam S |b 43 |
| 700 | 1 | _ | |a Krogh, Vittorio |b 44 |
| 773 | _ | _ | |a 10.1093/ajcn/nqaa157 |g p. nqaa157 |0 PERI:(DE-600)1496439-9 |n 3 |p 631-643 |t The American journal of clinical nutrition |v 112 |y 2020 |x 1938-3207 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:156857 |p VDB |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 12 |6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 13 |6 P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe |
| 913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-313 |2 G:(DE-HGF)POF3-300 |v Cancer risk factors and prevention |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
| 914 | 1 | _ | |y 2020 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2020-01-06 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |d 2020-01-06 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2020-01-06 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2020-01-06 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2020-01-06 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |d 2020-01-06 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2020-01-06 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |d 2020-01-06 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2020-01-06 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2020-01-06 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2020-01-06 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2020-01-06 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b AM J CLIN NUTR : 2018 |d 2020-01-06 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2020-01-06 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b AM J CLIN NUTR : 2018 |d 2020-01-06 |
| 920 | 1 | _ | |0 I:(DE-He78)C020-20160331 |k C020 |l C020 Epidemiologie von Krebs |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)C020-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|